In this article, we will discuss the 10 Best German Stocks to Buy According to Analysts.
The conflict in the Middle East has raised fears of economic damage as shipping costs and energy prices rise for American businesses. Amid growing concern that the US-Israel war with Iran will squeeze America’s consumers and businesses, investors are looking elsewhere for opportunities. In this condition, German stocks are emerging as ideals.
Germany is Europe’s largest economy. In 2025, Germany saw its GDP grow for the first time since 2022. In February, business confidence in the country improved more than expected, according to the Ifo Institute, which calculates an expectations index. That index shot up to 90.5% in February, compared to 89.6% in January.
“We stand by our forecast that the German economy is likely to grow more strongly this year than is generally expected,” Robin Winkler, Deutsche Bank’s chief Germany economist, told Bloomberg last month.
Big government spending on infrastructure and military is among the factors buoying business optimism in Germany.
The conflict in the Middle East is driving up energy prices around the world. But in Germany, a strong solar power output is easing energy cost pressures on businesses, according to a Bloomberg report on March 6.
As the economic sentiment in Germany turns more upbeat, let’s now look at the 10 best German stocks to buy according to analysts.
Our Methodology
To compile our list of the 10 best German stocks to buy according to analysts, we used screeners to make a list of publicly-traded German companies. Next, we picked out stocks with an average upside potential of at least 10%. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Best German Stocks to Buy According to Analysts
10. LuxExperience B.V. (NYSE:LUXE)
LuxExperience B.V. (NYSE:LUXE) is among the best German stocks to buy according to analysts. LuxExperience B.V. (NYSE:LUXE) has many events lined up, including the J.P. Morgan Retail Round Up Forum 2026 on April 8 and the Morgan Stanley Luxury Conference 2026 on May 19. These come as the company continues to work through its transformation plan focused on driving growth and improving profitability.
On February 18, JPMorgan analysts downgraded their LuxExperience stock rating from Overweight to Neutral and slashed the price target from $14 to $10. The analysts cited the change in the company’s share count for this action. Analyst Matthew Boss noted that while LuxExperience continues to execute on medium-term targets and has the potential to gain online luxury market share, the corrected share count results in a more balanced outlook.
In LuxExperience’s updated FYQ2 2026 earnings press release on February 12, the management issued a correction to state that the company had 140.1 million shares outstanding. The company was previously thought to have 87.2 million shares outstanding. This change led the JPMorgan market experts to adjust their estimates for LuxExperience.
In the Q2 report, which is for the period ended December 31, LuxExperience B.V. said its net sales rose 5.7% YoY, excluding foreign exchange impact, to €645.1 million. The company also said it returned to profitability in the quarter, reporting adjusted EBITDA margin of 2%. According to the management, the results confirm the progress of the company’s strategic transformation plan in which it targets €4bn billion in net sales and 7-9% in adjusted EBITDA margin in the medium-term.
LuxExperience raised its fiscal year 2026 outlook. It now expects GMV in the band of €2.5 billion to €2.7 billion. The previous forecast was for GMV coming in the range of €2.4 billion to €2.7 billion.
LuxExperience B.V. (NYSE:LUXE) is a German fashion department stores operator. It operates multiple online platforms that primarily target the luxury market.
9. Bayer AG (OTCMKTS: BAYRY)
Bayer AG (OTCMKTS:BAYRY) is among the best German stocks to buy according to analysts. On March 5, Bayer AG (OTCMKTS:BAYRY) announced that the FDA has cleared its MEDRAD MRXperion MR injector system for expanded application. That means this contrast injector system can now be used across a broader range of MRI scanners, including those with magnetic fields up to 7 Tesla.
Bayer’s MEDRAD MRXperion is used in MRI diagnostic procedures for delivering contrast agents and saline. This system is part of Bayer’s radiology segment where sales jumped 9% YoY to €2.2 billion in 2025.
Bayer released its Q4 and full-year 2025 earnings report on March 4. The report showed revenue rose 1.1% to €45.6 billion. That company absorbed €1.74 billion in adverse currency effects in 2025. For 2026, Bayer is expecting revenue in the band of €43.7 billion to €45.7 billion on a currency-adjusted basis. The company is anticipating EBITDA before special items to be in the range of €9.1 billion to €9.6 billion.
Regarding the 2026 outlook, Bayer CEO Bill Anderson said it reflects strong signs of progress in the company’s turnaround efforts. The executive added that the turnaround work is not complete yet.
As it looks forward to solid sales and stable earnings in 2026, Bayer is also working to contain litigation. The company’s CEO highlighted this effort in the 2025 earnings report, pointing to last month’s agreement to resolve claims around Roundup weedkiller.
Germany-headquartered Bayer AG (OTCMKTS:BAYRY) is a multinational pharmaceutical and biotechnology company. The company identifies health and agriculture as its core competencies. Bayer aims to create a world where there’s health for all and hunger for none. The company was founded in 1863.
8. Fresenius Medical Care AG (NYSE:FMS)
Fresenius Medical Care AG (NYSE:FMS) is among the best German stocks to buy according to analysts. On February 24, Fresenius Medical Care AG (NYSE:FMS) released its Q4 2025 results. The company posted EPS of €1.14, compared to €0.23 in the same quarter in 2024. It delivered revenue of €5.1 billion, flat from the year-ago quarter.
The management said the earnings numbers met internal targets, attributing this to efforts over the past three years that have focused on building a more resilient company. The management added that the achievements reflect a disciplined approach to operational and financial decisions.
Looking ahead, Fresenius Medical Care AG’s management spoke about further improving profitability, investing in the future, and overcoming regulatory headwinds. With this focus, the company is expecting 3% – 7% CAGR for operating income between 2025 and 2028. Additionally, the company aims to increase returns for shareholders.
In other news, Fresenius Medical Care AG has proposed a dividend of €1.49 per share based on 2025 earnings. The company said the proposed dividend is a 3% increase and represents a payout of about 33%. The company aims to maintain a stable dividend program at a payout ratio of 30% – 40%.
German healthcare company Fresenius Medical Care AG (NYSE:FMS) operates a network of 3,601 kidney dialysis clinics. These dialysis centers serve around 292,000 patients around the world. The company also provides dialysis machines.
7. Infineon Technologies AG (OTCMKTS:IFNNF)
Infineon Technologies AG (OTCMKTS:IFNNF) is among the best German stocks to buy according to analysts. On March 6, UBS downgraded its rating on Infineon Technologies AG (OTCMKTS:IFNNF) to Neutral from Buy and cut the price target to €45 from €47. For this action, UBS cited limited upside for Infineon’s AI business and a weakening Chinese auto market. Additionally, the firm pointed to Infineon’s delayed margin recovery.
According to UBS, Infineon’s AI revenue projection of €1.5 billion in 2026 and €2.5 billion in 2027 looks more optimistic than the reality. The firm sees the market growing more slowly than the German chipmaker anticipates.
On the China market, UBS sees a deteriorating market. According to the firm, China’s wholesale passenger vehicle volumes dropped 19% YoY and retail sales fell 14% in January 2026. In 2025, Infineon generated about 30% of its total revenue from China. Moreover, China is estimated to have contributed 43% of the company’s automotive revenue. In light of what it sees as a weakening market in China, UBS sees Infineon’s China auto revenue falling 7% in both 2026 and 2027.
On March 5, Infineon announced that it had completed a limited share repurchase program. It said that it bought back four million shares at an average price of €44.43, spending €177.7 million in total. On February 19, Infineon’s board approved a dividend of €0.35 per share based on the 2025 earnings.
The buyback and dividend plans followed the company’s better-than-expected FYQ1 2026 results. For the period ended December 31, Infineon posted revenue of €3.66 billion, exceeding the consensus expectation of €3.62 billion. The company’s Q2 revenue guidance of €3.8 billion is in line with analysts’ expectations.
Infineon Technologies AG (OTCMKTS:IFNNF) is a global chipmaker. The company’s chips are used in power systems, automotives, and other applications. Infineon was previously a unit of Siemens before its spinoff in 1999.
6. Deutsche Bank Aktiengesellschaft (NYSE:DB)
Deutsche Bank Aktiengesellschaft (NYSE:DB) is among the best German stocks to buy according to analysts. On March 4, JPMorgan named Deutsche Bank Aktiengesellschaft (NYSE:DB) among its top global investment bank stock picks. According to JPMorgan, the Middle East events have little direct impact on this German lender. It argues that the Middle East is a growth area for global banks like the Deutsche Bank, but the region’s contribution to the earnings of these global banks remains modest.
Additionally, JPMorgan points out that banks like Deutsche Bank generally have wholesale rather than domestic retail operations in the Middle East. Because these banks focus on institutional clients, JPMorgan suggests that higher volatility in the Middle East could actually benefit them through more trading revenue.
JPMorgan notes that Deutsche Bank trades at 7.6x P/E for 2027 estimates. Everything considered, the firm concludes that the market reaction on Deutsche Bank stock has been excessive.
On February 26, Deutsche Bank AG announced the commencement of its €1.0 billion share repurchase program. Combining this buyback with the proposed €1 per share dividend, Deutsche Bank said it was on course to return €2.9 billion to shareholders based on its 2025 earnings.
In other news, on February 19, Moody’s affirmed its A1 ratings for Deutsche Bank AG (NYSE:DB)’s long-term deposit and BAA2 ratings for the bank’s baseline credit assessment. It kept a stable outlook rating on the bank’s senior unsecured debt. Additionally, the rating agency upgraded its outlook for the bank’s deposit to positive from stable. In taking these actions, Moody’s pointed to Deutsche Bank’s conservative risk profile, diversified earnings profile, and robust liquidity buffers. The rating agency also noted the German lender’s 2028 strategic plan, where the bank targets its revenue to grow from €32.1 billion in 2025 to €37 billion.
Founded in 1870 and headquartered in Frankfurt, Deutsche Bank Aktiengesellschaft (NYSE:DB) is a German multinational bank company. It offers a broad array of banking and other financial services to institutional and retail clients.
5. Allianz SE (OTCMKTS:ALIZY)
Allianz SE (OTCMKTS:ALIZY) is among the best German stocks to buy according to analysts. On February 26, German insurance giant Allianz SE (OTCMKTS:ALIZY) released its Q4 and full-year 2025 report. For the quarter, the operating profit increased 3% YoY to €4.3 billion. For the full-year, the operating profit rose 8.4% to a record of €17.4 billion. Revenue for the year jumped 8.1% to €186.9 billion.
The 2025 results were buoyed by strengths in the property-casualty segment. Operating profit in this segment rose 13.9% to €9.0 billion. Asset Management posted a 3.3% jump in operating profit to €3.3 billion. The health division’s operating profit increased 1.7% to €5.6 billion.
For 2026, Allianz expects operating profit of €17.4 billion, give or take €1 billion. The consensus estimate calls for an operating profit of €18.1 billion.
In other news, Allianz announced a new share repurchase program on February 25. The insurer unveiled a €2.5 billion buyback plan, saying the program would begin in March 2026 and end in December 2026. The company says it will cancel the repurchased shares rather than keep them in its treasury. In addition to the buyback program, Allianz’s management has proposed a dividend per share of €17.10 for 2026.
Allianz SE (OTCMKTS:ALIZY) is a German global financial company better-known for its insurance business. It’s the world’s largest insurer. Beyond insurance, Allianz is engaged in asset management. The company was founded in 1890 and is headquartered in Munich, Germany.
4. Trivago NV (NASDAQ:TRVG)
Trivago NV (NASDAQ:TRVG) is among the best German stocks to buy according to analysts. In its Q4 2025 earnings report, released on February 3, Trivago NV (NASDAQ:TRVG) said its long-term strategy was playing out well, adding that it was confident it can continue to improve growth and profitability.
In Q4, the company’s revenue rose 27% YoY to €120 million. That growth was supported by a 17% jump in Referral revenue, which hit €109.4 million and accounted for the vast majority of the topline. Notably, the Q4 marked the fourth quarter in a row that the Referral business recorded a double-digit YoY revenue growth. The company’s net income for the quarter was €14.5 million. For the full year 2025, total revenue shot up 19% to €548.9. Net income for the year was €11.2 million, and the adjusted EBITDA came to €15.8 million.
Looking ahead to 2026, Trivago NV – ADR said it was off to an encouraging start to the year. For Q1 2026, it expects the double-digital revenue growth to continue. It also expects improved profitability. For full-year 2026, double-digital revenue growth is expected to continue, and adjusted EBITDA is expected to be at least €20 million.
The company sees factors such as continued product improvements and compounding brand effects driving growth in 2026.
Germany-based Trivago NV (NASDAQ:TRVG) operates a global platform for hotel search and price comparison. Trivago says it helps travelers book with confidence. Trivago’s platform provides access to over 7 million hotels in more than 190 countries.
3. SAP SE (NYSE:SAP)
SAP SE (NYSE:SAP) is among the best German stocks to buy according to analysts. On February 24, Bloomberg Law reported that German software company SAP SE (NYSE:SAP) had reached a settlement with Teradata over a long-running dispute. According to the report, the dispute arose in 2018 and hinged on trade secret and antitrust claims against SAP by Teradata. SAP reached a $480 million settlement with Teradata over the matter, averting a court trial that the report said was due to begin shortly.
In other news, SAP announced on February 19 that it planned to distribute €2.92 billion in dividends to shareholders based on its 2025 earnings. The dividend works out to €2.50 per share and represents a payout ratio of 40.7%. Notably, the per share dividend amount represents a 6.4% boost over the dividend the company distributed on its 2024 earnings. Another notable thing is that the payout ratio for 2024 was 52%. SAP plays to pay the dividend on May 8 to shareholders of record as of May 5.
SAP’s dividend boost for 2025 comes after the company reported an 8% jump in total revenue and a 111% rise in IFRS operating profit in the year. The results were supported by substantial growth in cloud revenue. SAP wrapped up the year with €3.4 billion in net liquidity, an increase from €1.7 billion in 2024.
SAP SE (NYSE:SAP) engages in software business, and it’s well-known for its enterprise resource planning software solution. Founded in 1972 and based in Walldorf, Germany, SAP is Germany’s largest enterprise software vendor.
2. Jumia Technologies AG (NYSE:JMIA)
Jumia Technologies AG (NYSE:JMIA) is among the best German stocks to buy according to analysts. On February 11, a day after Jumia Technologies AG (NYSE:JMIA) released its Q4 2025 results, Cantor Fitzgerald cut its price target on Jumia to $16 from $18 while maintaining an Overweight rating on the stock. In that report, the company posted GMV growth that fell short of Cantor’s expectations.
However, Cantor sees Jumia reaching EBITDA break-even by Q4 2026 and achieving full-year profitability in 2027. According to the firm, there’s more room for Jumia to penetrate Africa’s e-commerce market.
On February 10, online marketplace operator Jumia reported its Q4 2025 results. The report showed revenue rose 34% YoY to $61.4 million, though that still fell short of the $62.3 million that analysts were expecting. The topline was supported by a strong growth in GMV, which jumped 36% YoY to $279.5 million.
Adjusted EBITDA loss narrowed to $7.3 million compared to $13.7 million delivered in the fourth quarter of 2024.
The management said the company significantly reduced cash burn during Q4, saying this was supported by improving operating leverage. Jumia finished the quarter with $77.8 million in liquidity.
Looking ahead to 2026, Jumia management said it would focus on refining market footprint, optimizing cost structure, and unlocking operating leverage. Jumia projects GMV growth of between 27% and 32% in both Q1 2026 and full-year 2026.
Founded in 2012, Jumia Technologies AG (NYSE:JMIA) operates an online marketplace and offers logistics and payment services. The company is primarily focused on the African market. It is headquartered in Berlin, Germany.
1. Immatics N.V. (NASDAQ:IMTX)
Immatics N.V. (NASDAQ:IMTX) is among the best German stocks to buy according to analysts. On March 5, Immatics N.V. (NASDAQ:IMTX) reported its financial results for the year ended December 31. It also provided updates on its business.
On the financial part, the company reported revenue of $56.8 million, compared to revenue of $183.1 million in 2024. For the revenue change, the management explained that in 2024, there was a one-time non-cash revenue tied to the company’s deal with Bristol Myers Squibb.
Turning to the bottom line, the company posted a net loss of $230.8 million in 2025, which compared with a net profit of $17.9 million in 2024. The management said the loss was caused by lower non-cash revenue and higher costs associated with advancement of clinical programs.
On business update, Immatics N.V. said Phase 3 SUPRAME trial for its compound called anzu-cel (IMA203) was ongoing, and that the enrollment rate was strong. This trial is on the efficacy, safety, and tolerability of this drug candidate. The anzu-cel therapy is aimed at patients with certain types of melanoma. Immatics expects to begin final analyses of the study data later in 2026. It hopes to seek marketing approval for the drug candidate in the first half of 2027, and then launch the product on the market in the second half of 2027. The company has several other drug candidates in various stages.
Immatics N.V. finished the quarter with $551.4 million in cash and other financial assets.
Immatics N.V. (NASDAQ:IMTX) is a German clinical-stage biopharmaceutical company. It’s focused on developing treatments for cancer patients. Its lead drug candidate, Anzu-cel (IMA203), targets certain types of melanoma.
Disclosure: None. Follow Insider Monkey on Google News.
